NCT06224738 Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06222944 Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA Status NOT_YET_RECRUITING Phase PHASE2
NCT06221748 DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy Status RECRUITING Phase PHASE2/PHASE3
NCT06219941 AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 Status RECRUITING Phase PHASE2
NCT06213519 HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis Status NOT_YET_RECRUITING Phase PHASE2
NCT06206278 Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma Status TERMINATED Phase PHASE2
NCT06205173 Explored About Temperature Packing Care to Improve the Quality of Life for Chemotherapy Induced Peripheral Neuropathy (CIPN) in Colorectal Cancer and Gastric Cancer Patient Status COMPLETED Phase NA
NCT06204523 Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06202781 Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy Status RECRUITING Phase N/A
NCT06202716 Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore Status NOT_YET_RECRUITING Phase PHASE2
NCT06202105 Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer Status RECRUITING Phase NA
NCT06201585 Exploratory Study of Single-port Robot-assisted Gastrectomy Status NOT_YET_RECRUITING Phase NA
NCT06197438 Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06196554 Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs Status RECRUITING Phase N/A
NCT06194981 Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage Status RECRUITING Phase N/A
NCT06186089 Effect of Gastrectomy on Gut Microbiome and Cognitive Function Status RECRUITING Phase N/A
NCT06185907 In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors Status COMPLETED Phase N/A
NCT06182644 Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors Status RECRUITING Phase NA